This bill directs the Secretary of Health and Human Services to conduct a study assessing the safety, feasibility, and potential benefits of expanding the reprocessing of single-use medical devices.
Valerie Foushee
Representative
NC-4
This bill directs the Secretary of Health and Human Services to conduct a comprehensive study on the potential for expanding the safe and effective use of reprocessed single-use medical devices. The study will evaluate clinical safety, operational feasibility, and the environmental and financial impacts of reprocessing, with a focus on infection prevention. The findings and recommendations will be submitted to Congress within one year to help guide future policy and quality assurance standards.
When you head into a hospital, you probably assume that most of the plastic tools and gadgets used during your procedure are tossed in the trash immediately after. Currently, many of these are labeled as "single-use," creating a massive mountain of medical waste and driving up supply costs that eventually trickle down to your insurance premiums. This new bill directs the Secretary of Health and Human Services to conduct a deep-dive study into whether we can safely expand the practice of "reprocessing" these devices—essentially a high-tech, regulated version of cleaning and refurbishing them for another round of use. The bill sets a one-year deadline for a report to Congress, meaning we could see a major shift in hospital supply chains by late 2025.
This isn't about just rinsing off a syringe; the bill focuses on complex devices that could be safely sterilized and tested by specialized third-party companies. The study is required to look at the "operational feasibility" of this—checking if hospitals actually have the staff, tracking systems, and sterile processing equipment to handle more reused gear without compromising safety. For a surgical tech or a nurse, this could mean new protocols for how equipment is collected and tracked (Section 1). The bill specifically demands that patient safety and infection prevention remain the top priorities, requiring the FDA to categorize devices by risk. This means a simple tool might be cleared for reuse quickly, while high-risk internal devices would face much steeper hurdles.
The bill asks for a hard look at the "financial and environmental return" of switching to reprocessed gear. For the average patient or employer paying for health plans, this is where the impact hits home. If a hospital can buy a reprocessed device for a fraction of the cost of a brand-new one, it could potentially slow the rising costs of procedures. Environmentally, it’s a win for those concerned about the massive carbon footprint of medical manufacturing and disposal. However, the bill also smartly asks who is on the hook if something goes wrong. Section 1 requires an evaluation of liability—clarifying whether the original manufacturer, the reprocessor, or the hospital is responsible if a refurbished device fails during surgery.
Not everyone will be thrilled about this potential shift. Manufacturers of brand-new, single-use medical devices might see a dip in sales if hospitals start opting for "renewed" versions of their products. The bill acknowledges this friction by requiring the Secretary to investigate "contractual or technical barriers"—basically, looking into whether some manufacturers make devices that are intentionally impossible to clean or use legal contracts to prevent hospitals from using reprocessors. By the end of the year-long study, the government will produce a specific list of devices that are ready for prime-time reuse and those that need more research, potentially opening the door for a new industry of medical refurbishing that could make healthcare a little leaner and a lot greener.